Tuesday, July 21, 2026
Event Participants
Executives (2)
Dr. Gyanendra Shukla, Mr. Bhaskar Swaminathan
Analysts (8)
Abhijit Akella, Ankur Periwal, Gunjan Sharma, Himani Badetia, Praneet, Rajakumar V, Riju, Rohit Nagraj, Sonika Padulia
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Total Revenue | ₹1,022 cr | +7% YoY from ₹957 cr; volume growth ~2%, pricing growth ~5% |
| EBITDA | ₹184 cr | +23% YoY from ₹150 cr; margin expansion driven by price increases and product mix |
| Profit After Tax | ₹125 cr | +31% YoY from ₹95 cr; includes ₹2 cr exceptional gain on property sale |
| Crop Care Segment Revenue | ₹697 cr | +7% YoY from ₹652 cr; volume +2%, price +5% |
| Domestic (B2C) Revenue | ₹534 cr | +19% YoY from ₹449 cr; volume growth of 15% |
| Crop Protection Category | ₹455 cr | +18% YoY from ₹386 cr; volume growth of 16% |
| Soil & Plant Health | ₹62 cr | +10% YoY from ₹56 cr; price growth of 13% |
| Exports Revenue | ₹110 cr | -28% YoY from ₹152 cr; volumes down 35% due to weak Europe pendimethalin demand and China pricing pressure |
| CSM Revenue | ₹24 cr | +191% YoY from ₹8 cr; rebound in PEKK sales volumes |
| Total B2B Revenue | ₹163 cr | -19% YoY from ₹203 cr; volumes de-grew 26% |
| Seeds Revenue | ₹325 cr | +6% YoY from ₹305 cr; price growth of 6%, acreage drop in North Cotton |
| Cash & Liquid Balance | ₹309 cr | As of June 30, 2026 |
| Working Capital | +15-20 days | Net-net increase vs. prior year due to fertilizer-led cash crunch in channels |
Geographic & Segment Commentary
Crop Care (Domestic + Exports): Domestic B2C grew 19% driven by 15% volume growth, supported by aggressive preplacement, liquidation efforts, and new product promotions. Exports faced significant headwinds with revenue down 28%, attributed to lower pendimethalin demand in Europe, competitive Chinese pricing on Acephate, Pendi CS and Hexaconazole, plus port congestion and shipping delays. CSM emerged as a bright spot with 191% growth, boosted by PEKK volume rebound. Management highlighted focus on expanding customer base, optimizing product portfolio, rationalizing territories, and simplifying costs across the value chain.
Seeds: Revenue grew 6% to ₹325 cr, entirely price-led. The business experienced acreage drops in North Cotton and intense competition in South and Central cotton. Seed supply was sufficient but delayed due to non-availability of driers, processing facilities, concentrated arrivals and labour shortages. EBITDA margin improved from 26% to 30%, driven by favourable product mix—higher-margin rice, maize and millet replacing lower-margin, government-regulated cotton. Strategic focus remains on five crops: Cotton, Maize, Millet, Mustard and Rice. Inventory for cotton is elevated due to reduced plantings and illegal HTBT cotton spread, while rice/corn inventory surplus considered "a good problem to have."
Company-Specific & Strategic Commentary
New Product Launches: Launched 4 new crop care products—Balwan (Herbicide), Prodim Ultra (Herbicide), Kengen (Insecticide) and Aquafert Ginger & Turmeric (SPH). In Seeds, launched 2 new cotton hybrids for North India, Herbicide Tolerant Direct Seed Rice under Dhaanya brand, and short-duration Bajra varieties—total 9 products across Cotton, Millet and Paddy.
Digital & Channel Initiatives: Anubandh Edge retailer platform crossed 56,000 registered retailers. Farmers QR Code/Reward Schemes and Sampark+ farmer-level demand signal capture driving sales conversion. Digital-led field AV Van campaigns deployed. Idea2Impact open innovation platform received ~40 applications, with 2 in pilot stage.
Strategic Positioning: Management emphasized shifting toward high-margin, sustainable offerings including biologicals and next-generation products. R&D focus sharpened to 5 seed crops (discontinued vegetable seeds and GM crops), with portfolio department strengthened between marketing, R&D and sales. Building in-house capabilities in Soil & Plant Health while continuing third-party in-sourcing. EBITDA margin target of 500 bps improvement over 5 years reiterated, with goal of delivering 15%+ EBITDA margin even in a bad year.
Competitive Advantage: Brand strength, sharper R&D focus, digital-led customer outreach, aggressive seed and SPH expansion, and fixed-cost discipline cited as core competitive pillars for long-term value creation.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| Indian Agrochemicals Industry Growth (FY27) | 6–8% | Consensus estimate; price increases expected to drive growth, assuming no panic discounting |
| Seeds Industry Growth (FY27) | Mid-to-high single digits | Excluding cotton, which is expected to see significant decline due to acreage reduction |
| Export Growth | Challenging unless branded | CSM sustainable via contracts; catalogue products face China competition, particularly Acephate |
| Volume vs. Price Strategy | Volume priority | Management will strike a balance but give precedence to volume to capture market share from weaker small players |
| EBITDA Margin | 15%+ target even in bad year | Long-term structural goal; on track for 500 bps improvement over 5-year period |
| Cotton Business | Flat year expected | Management believes cotton will recover; rainfall situations like this are not annual occurrences |
Risks & Constraints
| Risk | Context |
|---|---|
| Monsoon / El Niño Risk | IMD projects below-normal rainfall at ~90% of LPA; rainfall deficit was 15% below normal as of 8 July 2026. Kharif sowing lagged ~21% YoY as of 5 July. Delayed sowing impacts agrochemical offtake timelines. Management notes 50%+ irrigated area provides buffer, and worst-case 90-95% crop planting expected, but crop mix shifts create uncertainty. |
| Middle East War / Input Costs | War elevated feedstock, energy and freight costs, compressing margins. Prices spiked initially, then tapered; however, recent escalation could re-tighten supply for rabi procurement starting August. Management stocked adequately for kharif but expects higher rabi input prices if conflict persists. |
| Chinese Competition in Exports | China continues to drive pricing pressure on APIs and intermediates. Acephate specifically challenged as raw material sourced from China, who competes directly in Brazil and US markets. Other products (Pendimethalin, Metribuzin, Hexaconazole, Metalaxyl) remain competitive. |
| Channel Working Capital Crunch | Fertilizer panic-buying diverted channel cash, delaying crop protection offtake and increasing industry working capital by 15-20 days. Returns risk elevated; management being more cautious with return provisions this year. |
| Illegal HTBT Cotton Spread | Widespread illegal HTBT cotton reduced legitimate seed demand in North India and impacted cotton acreage decisions, pressuring both seeds and crop protection portfolios. |
| Seed Production Risks | Open-field drying due to gas crisis during harvest reduced seed recovery. Industry has surplus inventory this year (comfortable), but October-November rains could delay next season's seed planting, creating future scarcity. |
Q&A Highlights
Exports & Competitive Landscape
- Question: How is product-wise demand and pricing in exports given Chinese competition continues to depress prices? (Ankur Periwal, Axis Capital)
- Answer: Exports are challenging unless branded. CSM is fine due to contracts; catalogue products must remain competitive. Acephate is the main challenge as raw materials come from China, who competes directly in Brazil/US. Other products remain competitive. First CSM shipments to a US customer were well-received; 3-4 products being worked on in parallel, but it's a "slow burn." (Gyanendra Shukla)
Cotton Outlook & Portfolio Impact
- Question: Given lower cotton acreage and portfolio heavy on cotton, what are thoughts on domestic growth? (Ankur Periwal)
- Answer: Cotton will be a flat year for the company. North cotton (Punjab/Haryana) saw significant acreage decline; South/Central impacted by rain-fed conditions and illegal HTBT cotton. Focus shifting to rice, maize and millet with new launches. However, lower acreage may be nullified if farmers get an open window to spray—last year crop was planted but rains in August-September prevented spraying. Cotton will recover; this is not an annual phenomenon. (Gyanendra Shukla)
El Niño Ground Reality & Volume Outlook
- Question: Has El Niño transpired on the ground? Will volumes be flattish or marginal degrowth? (Praneet, SJ Investments)
- Answer: El Niño is real, country saw deficit rainfall, but 50%+ area is irrigated. Delayed sowing has seen catch-up—pulses area up, groundnut down in Saurashtra, cotton lower, rice on track. Even in worst case, 90-95% of crop gets planted. Whether volumes are flat or degrow is situational—if 90% acreage gets more sprays to protect crops, industry volumes could still recover. Too early to predict; clearer picture by mid-August. (Gyanendra Shukla)
Pricing & Cost Pass-Through
- Question: Did the company pass on full raw material price increases? Will there be more price hikes? (Praneet)
- Answer: Price increases announced early (first to do so), but market acceptance only began in late May/June. Pass-through was full in some products, partial in others, none in some. Mid-season price increases are difficult. Marginal positive price impact expected for the year, but growth must come from volume. Organized players should capture share from small players facing working capital stress. (Gyanendra Shukla)
Channel Inventory & Returns
- Question: How is channel inventory and returns situation? (Praneet)
- Answer: Channel inventory has normalized versus a month ago. Product mix shifting—less pre-emergent herbicide demand in soybean, more post-emergent. Returns are product and crop specific; company being more cautious and provisioning more this year given uncertainty. (Gyanendra Shukla)
Long-Term Value Creation
- Question: What will be Rallis's strongest competitive advantage in a few years? What measurable outcomes should shareholders expect in 3 years? (Sonika Padulia, Millenium Mams)
- Answer: Brand is the biggest strength, plus sharper R&D focus, digital outreach, aggressive seeds and SPH expansion, and fixed-cost discipline. R&D stopped in vegetable seeds and GM crops; focused on 5 seed crops and building SPH capabilities. Goal: consistent 15%+ EBITDA margin even in a bad year; on track for 500 bps improvement over 5 years. Rallis should be "top of mind" as significant player in agriculture transformation delivering superior shareholder returns. (Gyanendra Shukla)
Employee Cost Provision Reversal
- Question: Can you explain the ₹35 cr provision reversal in employee cost and sharp increase in other expenses? (Abhijit Akella, Kotak Securities)
- Answer: Of the ₹35 cr, ₹10-11 cr is recurring—relates to performance incentive provisions settled in Q1 annually. Balance ₹24 cr is one-time restructuring and retiral-related reversal, not likely to repeat. Adjusted cost increase is ~12%, normal inflation. (Bhaskar Swaminathan)
Industry Growth Estimates Validation
- Question: Are 6-8% agrochemical and mid-to-high single digit seed growth estimates reasonable? (Abhijit Akella)
- Answer: Yes, excluding cotton from seed conversation. Agrochemical growth is achievable as price increases are a reality given input cost inflation. No panic discounting observed, indicating fairly balanced demand-supply. (Gyanendra Shukla)
Seed Inventory & Margins
- Question: Which crops drive higher inventory vs. last year? What drove seed EBITDA margin improvement from 26% to 30%? (Gunjan Sharma, Guruji Associates)
- Answer: Cotton inventory elevated due to delayed/reduced planting and illegal HTBT spread. Extra rice and corn inventory is "a good problem." Margin improvement driven by product mix—higher-margin rice, maize, millet replacing lower-margin cotton. Gas crisis forced open-field drying, reducing seed recovery, partially offsetting yield gains—analysis still in progress. (Gyanendra Shukla)
Direct Seeded Rice Opportunity
- Question: With paddy farmers shifting to DSR, how does this impact herbicide demand and does Rallis have portfolio? (Riju, Antique Stock Broking)
- Answer: DSR increases consumption of all herbicide categories. Rallis launched new rice herbicide, in-licensed DSR technology with pilot sales in Chhattisgarh. Herbicide is now the largest contributor among categories, growing 12% this quarter. (Gyanendra Shukla)
Key Takeaway
Rallis India delivered a resilient Q1 FY27 with revenue up 7% to ₹1,022 cr, EBITDA up 23% to ₹184 cr, and PAT up 31% to ₹125 cr, driven primarily by domestic strength (B2C +19%, crop protection +18%) with 15% volume growth, while exports declined 28% on China pricing pressure. Management navigated a weak demand environment characterized by El Niño-linked rainfall deficit (15% below normal), delayed kharif sowing (21% lower acreage YoY as of early July), and Middle East conflict-driven input cost inflation, countering with early price increases and aggressive channel management. Strategy centers on shifting mix toward high-margin segments—biologicals, Soil & Plant Health, non-cotton seeds (rice, maize, millet)—supported by digital initiatives (Anubandh Edge crossing 56,000 retailers) and a focused five-crop seed portfolio. FY27 guidance implies 6-8% industry growth driven by prices, with cotton as a deliberate underperformer. Key watch points: monsoon evolution through August, Middle East escalation impact on rabi input costs, export recovery in catalogue products, and working capital normalization as fertilizer-driven channel cash crunch resolves. Management remains cautiously optimistic, targeting capture of market share from smaller players facing liquidity stress.